Oxford BioDynamics (LON:OBD) Sets New 12-Month High – Here’s Why

Shares of Oxford BioDynamics Plc (LON:OBD) hit a new 52-week high on Wednesday . The stock traded as high as GBX 50.50 ($0.63) and last traded at GBX 0.51 ($0.01), with a volume of 221623344 shares. The stock had previously closed at GBX 0.50 ($0.01).

Oxford BioDynamics Price Performance

The company’s 50-day moving average is GBX 0.95 and its 200-day moving average is GBX 2.76. The firm has a market capitalization of £1.59 million, a price-to-earnings ratio of -8.50 and a beta of 0.42. The company has a debt-to-equity ratio of 370.22, a current ratio of 0.68 and a quick ratio of 2.80.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.